Search research articles
Contact Us
Filters
Showing results (141-150 of 150) with videos related to
Page
of 15
Sort By:
You have reached the last page of results.
This site can display upto 150 results.
BMC Biology
|
April 13, 2019
Derivation of adult canine intestinal organoids for translational research in gastroenterology
Lawrance Chandra, Dana C Borcherding, Dawn Kingsbury, et al.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi = Chinese Journal of Schistosomiasis Control
|
January 16, 2016
[Evaluation on molluscicidal effect of chlorosalicylicamide on Oncomelania hupensis in schistosomiaisis endemic areas of eight provinces in China]
Feng-hua Wei, Xing-jian Xu, Yi Yuan, et al.
Cancer Cell
|
April 18, 2025
Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiation
Mona Teng, Jiacheng Guo, Xin Xu, et al.
Alimentary Pharmacology & Therapeutics
|
March 31, 2026
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma (CHANCE2311)
Rong Ding, Jin-Feng Bai, Zhi-Cheng Jin, et al.
Nature Genetics
|
March 25, 2025
The landscape of N<sup>6</sup>-methyladenosine in localized primary prostate cancer
Xin Xu, Helen Zhu, Rupert Hugh-White, et al.
Hepatology (Baltimore, Md.)
|
November 10, 2025
Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204)
Zhi-Cheng Jin, Jingwei Wei, Yu-Dong Xiao, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
November 27, 2024
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213)
Zhi-Cheng Jin, Jia-Wei Zhou, Jian-Jian Chen, et al.
Eclinicalmedicine
|
May 15, 2024
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study
Zhi-Cheng Jin, Jian-Jian Chen, Xiao-Li Zhu, et al.
Aging Medicine (Milton (N.S.W))
|
July 7, 2025
Chinese Expert Consensus on Standardized Outpatient Management of Sarcopenia in the Elderly (2024)
Zhang Qin, Kang Lin, Wang Jianye, et al.
Signal Transduction and Targeted Therapy
|
February 8, 2023
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)
Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, et al.
Page
of 15
Search research articles
Search
Showing results (141-150 of 150) with videos related to
Sort By:
Page
of 15
You have reached the last page of results.
This site can display upto 150 results.
BMC Biology
|
April 13, 2019
Derivation of adult canine intestinal organoids for translational research in gastroenterology
Lawrance Chandra, Dana C Borcherding, Dawn Kingsbury, et al.
Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi = Chinese Journal of Schistosomiasis Control
|
January 16, 2016
[Evaluation on molluscicidal effect of chlorosalicylicamide on Oncomelania hupensis in schistosomiaisis endemic areas of eight provinces in China]
Feng-hua Wei, Xing-jian Xu, Yi Yuan, et al.
Cancer Cell
|
April 18, 2025
Circular RMST cooperates with lineage-driving transcription factors to govern neuroendocrine transdifferentiation
Mona Teng, Jiacheng Guo, Xin Xu, et al.
Alimentary Pharmacology & Therapeutics
|
March 31, 2026
Camrelizumab and Apatinib With or Without Transarterial Chemoembolisation as First-Line Treatment for Advanced Hepatocellular Carcinoma (CHANCE2311)
Rong Ding, Jin-Feng Bai, Zhi-Cheng Jin, et al.
Nature Genetics
|
March 25, 2025
The landscape of N<sup>6</sup>-methyladenosine in localized primary prostate cancer
Xin Xu, Helen Zhu, Rupert Hugh-White, et al.
Hepatology (Baltimore, Md.)
|
November 10, 2025
Decoding tumor heterogeneity with imaging biomarkers predicts response to TACE plus immunotherapy and targeted therapy in HCC (CHANCE2204)
Zhi-Cheng Jin, Jingwei Wei, Yu-Dong Xiao, et al.
Journal of Cachexia, Sarcopenia and Muscle
|
November 27, 2024
Longitudinal Body Composition Identifies Hepatocellular Carcinoma With Cachexia Following Combined Immunotherapy and Target Therapy (CHANCE2213)
Zhi-Cheng Jin, Jia-Wei Zhou, Jian-Jian Chen, et al.
Eclinicalmedicine
|
May 15, 2024
Immune checkpoint inhibitors and anti-vascular endothelial growth factor antibody/tyrosine kinase inhibitors with or without transarterial chemoembolization as first-line treatment for advanced hepatocellular carcinoma (CHANCE2201): a target trial emulation study
Zhi-Cheng Jin, Jian-Jian Chen, Xiao-Li Zhu, et al.
Aging Medicine (Milton (N.S.W))
|
July 7, 2025
Chinese Expert Consensus on Standardized Outpatient Management of Sarcopenia in the Elderly (2024)
Zhang Qin, Kang Lin, Wang Jianye, et al.
Signal Transduction and Targeted Therapy
|
February 8, 2023
Transarterial chemoembolization with PD-(L)1 inhibitors plus molecular targeted therapies for hepatocellular carcinoma (CHANCE001)
Hai-Dong Zhu, Hai-Liang Li, Ming-Sheng Huang, et al.
Page
of 15